Anticoagulation for the Prevention of Arterial Thrombosis in Ambulatory Cancer Patients: Systematic Review and Meta-Analysis.

ABSTRACT:

Background

The risk of arterial thrombotic events (ATEs) is high among patients on systemic anticancer therapies. Despite the efficacy of anticoagulants in the prevention of cancer-associated venous thromboembolism, it is unknown whether anticoagulation is effective to prevent ATEs.

Objectives

This study sought to examine the efficacy and safety of anticoagulants in ATE prevention among ambulatory cancer patients.

Methods

We performed a systematic review using Medline, Embase, Scopus, and Cochrane Central Register of Controlled Trials (CENTRAL) from inception to May 21, 2022, and included studies comparing oral or parenteral anticoagulation with no anticoagulation among ambulatory patients receiving systemic anticancer therapy with no other indication for anticoagulat

SUBMITTER: Xu Y 

PROVIDER: S-EPMC10443118 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature